Procyon Corp (PCYN) financial statements (2020 and earlier)

Company profile

Business Address 1300 S HIGHLAND AVE
CLEARWATER, FL 33756
State of Incorp. CO
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments97289290253336449270
Cash and cash equivalents97289290253336449270
Receivables632519420416316427372
Inventory, net of allowances, customer advances and progress billings591426485432487321417
Inventory591426485432487321417
Other undisclosed current assets434421398497382340325
Total current assets:1,7531,6551,5941,5981,5201,5371,384
Noncurrent Assets
Property, plant and equipment472478488482494506512
Other noncurrent assets418396353398414391462
Total noncurrent assets:889874841880908898974
TOTAL ASSETS:2,6422,5292,4352,4782,4282,4352,358
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities113116228169198130229
Accounts payable113116 169198130 
Accrued liabilities  55   50
Employee-related liabilities  174   179
Debt4548  012
Other undisclosed current liabilities33620714719317918595
Total current liabilities:494372376362377316326
Noncurrent Liabilities
Long-term debt and lease obligation1221     
Operating lease, liability1221  
Total noncurrent liabilities:1221     
Total liabilities:507393376362377316326
Stockholders' equity
Stockholders' equity attributable to parent, including:2,1362,1362,0592,1162,0512,1192,032
Common stock4,4454,4454,4454,4454,4454,4354,435
Additional paid in capital16161616161616
Accumulated deficit(2,452)(2,452)(2,529)(2,472)(2,537)(2,468)(2,556)
Other undisclosed stockholders' equity attributable to parent127127127127127137137
Total stockholders' equity:2,1362,1362,0592,1162,0512,1192,032
TOTAL LIABILITIES AND EQUITY:2,6422,5292,4352,4782,4282,4352,358

Income statement (P&L) ($ in thousands)

12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
Revenues1,1281,1831,1151,0719141,0911,064
Cost of revenue
(Cost of Goods and Services Sold)
(325)(320)(309)(289)(240)(304)(291)
Gross profit:803863807782675786773
Operating expenses(800)(748)(845)(695)(748)(665)(765)
Operating income (loss):3115(39)87(73)1228
Nonoperating income (expense)101110(0)
Investment income, nonoperating101110 
Income (loss) from continuing operations before income taxes:4115(38)88(72)1228
Income tax expense (benefit)(4)(32)(19)(23)4(35)46
Net income (loss):(0)84(57)65(68)8754
Other undisclosed net income attributable to parent0      
Net income (loss) attributable to parent:(0)84(57)65(68)8754
Preferred stock dividends and other adjustments(4)(4)(4)(4)(4)(4)(4)
Other undisclosed net loss available to common stockholders, basic(0)      
Net income (loss) available to common stockholders, diluted:(4)80(61)61(72)8349

Comprehensive Income ($ in thousands)

12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
Net income (loss):(0)84(57)65(68)8754
Comprehensive income (loss), net of tax, attributable to parent:(0)84(57)65(68)8754

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: